Designation highlights significant unmet needs in DMD; dystrophin data from potentially registrational...
Successful clinical translation of Waveโs RNA medicines platform in HD patients with WVE-003 provides further...
CAMBRIDGE, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage...
Statistically significant, potent, and durable allele-selective silencing: 46% mean reduction in CSF mutant...
Presentation at the Obesity & Weight Loss Drug Development Summit to review Real World Evidence for the...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.